Clin2
NCT07101640Possibly a fitRecruiting

Montelukast study for breathing problems in premature infants

Bronchopulmonary Dysplasia (BPD)Premature BirthsCritical Illness

Treatments studied

Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.

This trial tests if the medicine montelukast can help very premature babies on breathing machines. It aims to see if it improves lung development and makes it easier for them to breathe on their own.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
28 people
Ages
1 week to 4 weeks
Study type
Interventional

Who can take part

  • Baby is on a breathing machine (ventilator) and needs extra oxygen
  • Born before 28 weeks of pregnancy and weighed less than 2.2 pounds at birth
  • Baby is 7 to 28 days old when starting the study medicine
  • Parents or guardians have agreed in writing (informed consent)
  • Baby can handle small feedings (5 mL) through a tube into the stomach

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07417111Recruiting
CPAP breathing support for very premature babies

This study looks at whether a careful CPAP breathing support plan helps very premature babies breathe better. It may be an option for babies who are stable on low oxygen settings and have few breathing pauses.

Birmingham, Alabama
NCT07052201Not yet recruiting· Phase 3
Dexamethasone for preventing lung disease in premature babies

This study tests whether a medicine called dexamethasone (a steroid) can help prevent a serious lung problem in very premature babies. It is for babies who still need a breathing machine after two weeks of life.

Hangzhou, Zhejiang
NCT07058025Not yet recruiting· Phase 2
Stem cell therapy to prevent lung damage in premature babies

This trial tests whether giving stem cells to very premature babies can help prevent bronchopulmonary dysplasia, a lung condition that often affects babies born before 28 weeks. The stem cells are given through an IV, and the study compares them to a placebo to see if they improve lung health.

Edmonton, Alberta
NCT06776783Recruiting· Phase 3
Testing a new surfactant for breathing problems in premature babies

This study tests a new medicine called APC-0101, a type of surfactant, for premature babies with breathing problems (respiratory distress syndrome). It may help their lungs work better and reduce the need for more breathing support.

Little Rock, Arkansas
NCT07770464Recruiting· Phase 2
Montelukast for acute bronchiolitis in infants

This study tests whether montelukast, a medicine that helps reduce airway inflammation, can improve symptoms of acute bronchiolitis (a common lung infection in babies) when given early. It may help babies breathe easier and recover faster.

Islamabad, Federal
NCT06855043Not yet recruiting· Phase 1/Phase 2
Early treatment to help premature babies' lungs grow

This study tests an experimental treatment to help premature babies' lungs grow stronger and reduce the need for a breathing machine. It might help your baby if they are very premature and still need extra oxygen and breathing support.

Madison, Wisconsin

Hear when a new Bronchopulmonary Dysplasia (BPD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.